Louise Rodino-Klapac insider trades
Open-market stock purchases and sales by Louise Rodino-Klapac, President, R&D and Tech Ops at Sarepta Therapeutics, Inc, from SEC Form 4 filings since Dec 14, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -80%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 11, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $16.1K |
| Mar 9, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $8.5K |
| Mar 9, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $15.2K |
| Mar 2, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $60.2K |
| Mar 2, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $12.4K |
| Mar 1, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Nov 17, 2025 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $84.4K |
Companies traded
- SRPT Sarepta Therapeutics, Inc: 1 buy, last Mar 11, 2026
Get free alerts when Louise Rodino-Klapac files a new trade →